Pharma-Bio Serv (PBSV) Loans and Notes Receivables (2018 - 2020)

Pharma-Bio Serv (PBSV) has 3 years of Loans and Notes Receivables data on file, last reported at $1.2 million in Q4 2020.

• For the quarter ending Q4 2020, Loans and Notes Receivables changed 0.0% year-over-year to $1.2 million; the trailing twelve-month figure through Oct 2020 stood at $1.2 million (changed 0.0% YoY), and the FY2020 full-year result was $1.2 million, changed 0.0% from the prior year.
• Loans and Notes Receivables for Q4 2020 stood at $1.2 million, roughly flat from $1.2 million in the prior quarter.
• Across five years, Loans and Notes Receivables topped out at $1.8 million in Q4 2018 and bottomed at $1.2 million in Q4 2019.
• The 3-year median for Loans and Notes Receivables is $1.2 million (2019), against an average of $1.4 million.
• The widest annual swing landed in 2019, when Loans and Notes Receivables dropped 28.57%; it then changed 0.0% in 2020.
• A 3-year view of Loans and Notes Receivables shows it stood at $1.8 million in 2018, then decreased by 28.57% to $1.2 million in 2019, then changed by 0.0% to $1.2 million in 2020.
• The last three Loans and Notes Receivables figures came in at $1.2 million (Q4 2020), $1.2 million (Q4 2019), and $1.8 million (Q4 2018), per Business Quant data.

Peer Comparison